Clinical trial
Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
NCT00277823
Study timeline
Study start (unknown)2006-02-01Date precision: month
Registry last updated2007-12-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
Sponsors & collaborators
Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor
Mapped research locations
New YorkNew York, United States2PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1SeattleWashington, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1Oklahoma CityOklahoma, United States1Salt Lake CityUtah, United States1CharlestonSouth Carolina, United States1New OrleansLouisiana, United States1DaytonOhio, United States1ToledoOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00277823 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.